readthroughSign in
CompanyEXELNasdaqAlameda, CA

Exelixis

Exelixis develops small molecule and biotherapeutic oncology medicines.

10-QNov 16Latest SEC filing
Nov 12Latest story

November 2026

October 2026

September 2026

August 2026

July 2026